Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA1203 in Advanced Solid Tumors
NCT07876609Phase 1Recruiting
- Sponsor
- Boan Biotech
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BA1203 in solid tumor, sponsored by Boan Biotech. Primary endpoints: Adverse Events, Dose Limiting Toxicities and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
BA1203
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07876609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876609.